Ligand validation:4LRL

DGT: 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

DGT is a Ligand Of Interest in 4LRL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LRL_DGT_B_502	79%	44%	0.112	0.957	0.88	1.29	1	4	1	0	100%	0.968
4LRL_DGT_A_502	75%	41%	0.118	0.95	0.8	1.48	-	5	0	0	100%	0.968
4LRL_DGT_D_502	70%	44%	0.138	0.955	0.99	1.19	1	2	0	0	100%	0.968
4LRL_DGT_C_502	69%	46%	0.114	0.929	0.82	1.24	1	4	0	0	100%	0.968
3IRH_DGT_B_458	70%	48%	0.133	0.952	0.84	1.16	1	4	0	0	100%	1
3F2C_DGT_A_1456	99%	30%	0.06	0.989	0.96	1.8	1	6	13	0	100%	1
8ILD_DGT_A_201	98%	44%	0.057	0.982	0.9	1.26	1	5	0	0	100%	1
7U78_DGT_A_506	98%	44%	0.052	0.974	0.95	1.21	3	3	1	0	100%	0.85
3F2D_DGT_A_1456	98%	29%	0.065	0.985	0.96	1.84	-	7	11	0	100%	1
1XJJ_DGT_A_1001	98%	21%	0.064	0.983	1.71	1.63	4	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.